Nanovibronix, Inc. (NASDAQ:FEED – Get Free Report) saw a significant drop in short interest during the month of August. As of August 31st, there was short interest totaling 87,719 shares, a drop of 74.5% from the August 15th total of 344,075 shares. Based on an average daily volume of 212,831 shares, the short-interest ratio is presently 0.4 days. Approximately 10.8% of the shares of the company are short sold.
Insider Activity at Nanovibronix
In other news, insider Christian Michael Glibert sold 17,500 shares of the business’s stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $8.28, for a total value of $144,900.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 12.20% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
A number of research analysts have weighed in on FEED shares. Wall Street Zen raised shares of Nanovibronix from a “strong sell” rating to a “sell” rating in a research report on Sunday, July 12th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nanovibronix in a research note on Tuesday, July 21st. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has an average rating of “Sell”.
Nanovibronix Stock Up 0.3%
Nanovibronix stock traded up $0.01 during mid-day trading on Friday, reaching $3.58. The company had a trading volume of 10,931 shares, compared to its average volume of 54,630. The firm has a market cap of $3.30 million, a price-to-earnings ratio of -0.03 and a beta of 1.38. The company has a 50 day moving average of $4.69 and a 200-day moving average of $12.26. Nanovibronix has a 52 week low of $3.48 and a 52 week high of $208.80.
Nanovibronix (NASDAQ:FEED – Get Free Report) last announced its quarterly earnings data on Monday, August 17th. The company reported ($23.76) EPS for the quarter. The company had revenue of $0.24 million for the quarter. Nanovibronix had a negative net margin of 1,093.61% and a negative return on equity of 60.73%.
About Nanovibronix
Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.
The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.
See Also
- Five stocks we like better than Nanovibronix
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for Nanovibronix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanovibronix and related companies with MarketBeat.com's FREE daily email newsletter.
